CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION
发明人:
BURAK, Eric Steven,SIMMS, Ryan Wayne,VALLIANT, John Fitzmaurice,FORBES, John Richard,MORAN, Matthew David Burr,DARWISH, ALLA
申请号：
CL2019003169
公开号：
CL2019003169A1
申请日:
2019.11.05
申请国别(地区):
CL
年份:
2020
代理人:
摘要：
N refers to polymers, including met amp, Aacute, LiCo and other therapies and combinations of amperometric, eacute, utico or leadership, M amp, eacute, a complex all used in the production and use of amperometric, oacute, N and other therapies. The present invention is directed against monoclonal antibody, which is similar to insulin and radioimmunococcus, showing higher power and improving excreta and thyroid gland； oacute； n； or met amp complex； Aacute； folic acid, which is the receptor of growth factor 1, When it's combined with other therapies and amperes, use, use, a fraction and ampere, oacute, directional,Or a set of retinograms； oacete； n., on the other hand, invention and amp； oacute； n present component and amp； oacute； n Pharmacopoeia and amp； eacute； Utica, including an invention and amp compound； oacute； n； and a former pharmacist and amp； eacute； are actually acceptable. On the other hand, the invention and amp； oacute； n shows an M amp； eacute； all planned CI amp； oacute； raici amp； oacute； N and / or raici amp； treatment； oacute； N, M amp； eacute； all of which include the management of a body that requires a compound, a compound CI amp； oacute； n Pharmacopoeia amp； eacute； Utica de la investigaci amp； oatt. /P GT；<；p>；LA PRESENTE INVENCIÓ；N SE REFIERE A CONJUGADOS QUE INCLUYEN UN RESTO QUELANTE DE UN COMPLEJO METÁ；LICO DEL MISMO Y UN RESTO TERAPÉ；UTICO O DIRIGIDO, MÉ；TODOS PARA SU PRODUCCIÓ；N Y USOS DE LOS MISMOS. LA PRESENTE INVENCIÓ；N ESTÁ； DIRIGIDA A ANTICUERPOS MONOCLONALES QUE SE DIRIGEN AL RECEPTOR DEL FACTOR DE CRECIMIENTO 1 SIMILAR A LA INSULINA Y A LOS RADIOINMUNOCONJUGADOS DEL MISMO QUE DEMUESTRAN UNA MAYOR POTENCIA Y MEJORAN LA EXCRECIÓ；N DE UN RESTO QUELANTE, O UN COMPLEJO METÁ；LICO DEL MISMO, CUANDO SE CONJUGA CON UN RESTO TERAPÉ；UTICO, UN FRACCIÓ；N DIRIGIDA, O UN GRUPO DE RETICULACIÓ；N. EN OTRO ASPECTO, LA INVENCIÓ；N PRESENTA UNA COMPOSICI&Oa
